ArticleFrontiers in surgery2025
Meningeal metastatic tumor with bone destruction from follicular thyroid carcinoma: a case report and literature review.
Article in Frontiers in surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Follicular thyroid carcinoma (ftc) is a malignant neoplasm arising from thyroid follicular epithelial cells and is the second most common thyroid cancer after papillary thyroid carcinoma. meningeal metastasis from ftc with calvarial destruction is exceedingly rare and is often misdiagnosed clinically as meningioma. we reviewed previously reported cases in the literature and, in addition, report and include one case of meningeal metastasis from ftc treated at our center. Methods: Using the keywords "meningioma," "follicular thyroid carcinoma," and "cerebral metastatic tumor," we searched PubMed/MEDLINE and Web of Science to identify relevant publications. We extracted patient age, sex, tumor location and size, treatment modalities, and follow-up outcomes. In parallel, we provide a detailed description and analysis of the clinical course of the present case. Results: A total of 10 patients were included, comprising the cases reported in the literature and the index case in this study. The mean age was 60.5 years, and most lesions were solitary epidural or dural-based masses. Headache was the most common presenting symptom. All patients underwent surgical resection; postoperative recurrence occurred in two cases, and the longest survival on follow-up was 7 years. Conclusions: Meningeal metastasis from FTC is rare and typically presents as a dural-based mass that readily mimics meningioma. Gross-total resection can achieve favorable initial disease control, although recurrence may still occur. Given the small number of reported cases, the long-term prognosis remains uncertain and warrants further investigation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.